Katholisches Krankenhaus St. Johann Nepomuk
About Katholisches Krankenhaus St. Johann Nepomuk
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Center for Sepsis Control and Care, Germany
1
Light Sciences Oncology
1
Martin-Luther-Universität Halle-Wittenberg
1
Resverlogix Corp
1
Clinical Trials at Katholisches Krankenhaus St. Johann Nepomuk
During the past decade, Katholisches Krankenhaus St. Johann Nepomuk conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases
2007-02-01
2011-10-01
Completed
483
Medical Education for Sepsis Source Control and Antibiotics
2011-07-01
2013-07-01
Completed
4,138
Efficacy of FOLFOX+Bevacizumab in Combination With Irinotecan in the Treatment of Metastatic Colorectal Cancer
2011-05-01
2018-08-15
Completed
250
Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD
2015-11-01
2021-06-21
Completed
2,425
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Katholisches Krankenhaus St. Johann Nepomuk"
#1 collaborator was "ICON plc" with 1 trials as a collaborator, "Medidata Solutions" with 1 trials as a collaborator, "PPD" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Katholisches Krankenhaus St. Johann Nepomuk
According to Clinical.Site data, the most researched conditions in "Katholisches Krankenhaus St. Johann Nepomuk" are
"Colorectal Neoplasms" (1 trials), "Coronary Artery Disease" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Liver Metastases" (1 trials) and "Metastatic Colorectal Cancer" (1 trials). Many other conditions were trialed in "Katholisches Krankenhaus St. Johann Nepomuk" in a lesser frequency.
Clinical Trials Intervention Types at Katholisches Krankenhaus St. Johann Nepomuk
Most popular intervention types in "Katholisches Krankenhaus St. Johann Nepomuk" are "Drug" (3 trials), "Behavioral" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "5FU/LV, Oxaliplatin, Bevacizumab, Irinotecan" (1 trials), "Apabetalone" (1 trials), "Atorvastatin" (1 trials), "Change Management" (1 trials) and "FOLFIRI regimen" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Katholisches Krankenhaus St. Johann Nepomuk
The vast majority of trials in "Katholisches Krankenhaus St. Johann Nepomuk" are
4 trials for "All" genders.
Clinical Trials Status at Katholisches Krankenhaus St. Johann Nepomuk
Currently, there are NaN active trials in "Katholisches Krankenhaus St. Johann Nepomuk".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Katholisches Krankenhaus St. Johann Nepomuk,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Katholisches Krankenhaus St. Johann Nepomuk, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".